Associação entre a presença de esteatose hepática não alcoólica em mulheres com ovários micropolicísticos / Association between the presence of nonalcoholic fatty liver disease in women with micropolycystic ovaries

Juliana Monroy Leite, Rodrigo Herman Costa de Araújo, Ellen Priscila Graça e Silva, Allana Vitória Oliveira Teixeira, Mirna Lopes Peres, Catarina Fagundes Moreira, Josilda Ferreira Cruz

Abstract


A síndrome dos ovários policísticos é a desordem endócrina mais comum em mulheres na idade reprodutiva. É constituída por um espectro de apresentações clínicas e está associada à obesidade, resistência à insulina, síndrome metabólica e inflamação crônica de baixo grau. Frequentemente, está associada a outras doenças metabólicas. A doença hepática gordurosa não alcoólica (DHGNA), por sua vez, é considerada a manifestação hepática da síndrome metabólica, também inserida em um contexto de disfunções metabólicas e associa-se à síndrome dos ovários policísticos. Assim, esse projeto visa associar a presença de DHGNA em mulheres com ovários micropolicísticos através de exames ultrassonográficos. Trata-se de um estudo clínico, transversal com abordagem descritiva, realizado em um centro especializado em exames de imagem e laboratoriais de Aracaju-SE. O processo de coleta de dados foi dividido em 3 etapas e os dados obtidos foram compilados no programa Microsoft Office Excel versão 2016. O estudo foi aprovado por Comitê de Ética em Pesquisa. Foram analisados 48 pacientes do sexo feminino com idade entre 17 e 51 anos, sendo a mediana 30,8  anos. A maioria das pacientes não apresentavam esteatose hepática  (62,5%) e não apresentavam ovários micropolicísticos (54,2%)  Entretanto, 11  pacientes (22,91%) apresentavam ovários micropolicisticos e algum grau de esteatose hepática não gordurosa. Não houve associação estatisticamente significativa entre a presença de ovários micropolicísticos e gravidade da esteatose hepática gordurosa não alcoólica, muito embora a frequência da associação da DHGNA e ovários micropolicísticos foi semelhante à encontrada em outros estudos


Keywords


hepatopatia gordurosa não alcoólica, fígado, ovários micropolicisticos.

References


Stein I, Leventhal M. Amenorrhea Associated with Bilateral Polycystic Ovaries. Am J Obst Gynecol. 1935; 29(2):181-91.

Knochenhauer E, Key T, Kahsar-Miller M, Waggoner W, Boots L, Azziz R. Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study1. J Clin Endocrinol Met. 1998; 83(9):3078-82.

Diamanti-Kandarakis E, Kouli C, Bergiele A, Filandra F, Tsianateli T, Spina G, et al. A Survey of the Polycystic Ovary Syndrome in the Greek Island of Lesbos: Hormonal and Metabolic Profile. J Clin Endocrinol Met. 1999; 84(11):4006-11.

Michelmore K, Balen A, Dunger D, Vessey M. Polycystic Ovaries and Associated Clinical and Biochemical Features in Young Women. Obst Gynecol Surv. 2000; 55(8):494-6.

Asunción M, Calvo R, San Millán J, Sancho J, Avila S, Escobar-Morreale H. A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain. J Clin Endocrinol Met. 2000; 85(7):2434-8.

Azziz R, Woods K, Reyna R, Key T, Knochenhauer E, Yildiz B. The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population. J Clin Endocrinol Met. 2004; 89(6):2745-9.

Melo A, Vieira C, Barbieri M, Rosa-e-Silva A, Silva A, Cardoso V, et al. High prevalence of polycystic ovary syndrome in women born small for gestational age. Hum Reprod. 2010; 25(8):2124-31.

Fauser B, Tarlatzis B, Rebar R, Legro R, Balen A, Lobo R, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fert Ster. 2012; 97(1):28-38.e25.

Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz B. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016; 31(12):2841-55.

Kazer R, Kessel B, Yen S. Circulating Luteinizing Hormone Pulse Frequency in Women with Polycystic Ovary Syndrome. J Clin Endocrinol Met. 1987; 65(2):233-6.

Foecking E, Szabo M, Schwartz N, Levine J. Neuroendocrine Consequences of Prenatal Androgen Exposure in the Female Rat: Absence of Luteinizing Hormone Surges, Suppression of Progesterone Receptor Gene Expression, and Acceleration of the Gonadotropin-Releasing Hormone Pulse Generator. Biol Reprod. 2005; 72(6):1475-83.

Nestler J, Powers L, Matt D, Steingold K, Plymate S, Rittmaster R, et al. A Direct Effect of Hyperinsulinemia on Serum Sex Hormone-Binding Globulin Levels in Obese Women with the Polycystic Ovary Syndrome. J Clin Endocrinol Met. 1991; 72(1):83-9.

Daniels T, Berga S. Resistance of Gonadotropin Releasing Hormone Drive to Sex Steroid-Induced Suppression in Hyperandrogenic Anovulation. J Clin Endocrinol Met. 1997; 82(12):4179-83.

Pastor C, Griffin-Korf M, Aloi J, Evans W, Marshall J. Polycystic Ovary Syndrome: Evidence for Reduced Sensitivity of the Gonadotropin-Releasing Hormone Pulse Generator to Inhibition by Estradiol and Progesterone. J Clin Endocrinol Met. 1998; 83(2):582- 90.

Ehrmann D. Polycystic Ovary Syndrome. New Engl J Med. 2005; 352(12):1223-36.

Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale H, Franks S, Gambineri A, et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol. 2014; 171(4):P1-P29.

Yildiz B. Assessment, diagnosis and treatment of a patient with hirsutism. Nat Clin Pract Endocrinol Met. 2008; 4(5):294-300.

Dewailly D, Lujan M, Carmina E, Cedars M, Laven J, Norman R, et al. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2013; 20(3):334-52.

Sanyal A. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002; 123(5):1705-25.

Cordeiro A, Pereira S, Saboya C, Ramalho A. Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals. BioMed Res Int. 2015; 2015:1-7.

Ferolla S. Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease. World J Hepatol. 2015; 7(3):559.

Corrado R, Torres D, Harrison S. Review of Treatment Options for Nonalcoholic Fatty Liver Disease. Med Clin North Am. 2014; 98(1):55-72.

Vernon G, Baranova A, Younossi Z. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Alim Pharm Therap. 2011; 34(3):274-85.

Younossi Z, Koenig A, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016; 64(1):73-84.

Lazo M, Clark J. The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective. Sem Liver Dis. 2008; 28(4):339-50.

Chen M, Ho H. Hepatic manifestations of women with polycystic ovary syndrome. Best Prac Res Clin Obst Gynaec. 2016; 37:119-28.

Yilmaz M, Bukan N, Demırcı H, Öztürk Ç, Kan E, Ayvaz G, et al. Serum resistin and adiponectin levels in women with polycystic ovary syndrome. Gynecol Endocrinol. 2009; 25(4):246-252.

Chalasani N, Younossi Z, Lavine J, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2017; 67(1):328-57.

Chalasani N, Younossi Z, Lavine J, Diehl A, Brunt E, Cusi K, et al. The diagnosis and management of non- alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012; 55(6):2005-23.

Lozano Zalce H, González Silva N. Obesidad, síndrome metabólico, esteatohepatitis no alcohólica y su diagnóstico con elastografía por ultrasonido. Acta Médica Grupo Ángeles. 2018;16(4):382-387.

COTRIM, Helma P. et al. NONALCOHOLIC FATTY LIVER DISEASE BRAZILIAN SOCIETY OF HEPATOLOGY CONSENSUS. Arquivos de Gastroenterologia, v. 53, n. 2, p. 118-122, 2016;

Carmina E, Azziz R. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertility and Sterility. 2006;86 Suppl 1:S7-8.

Spritzer PM, Wiltgen D. Prevalence of metabolic syndrome in patients of south of Brazil with polycystic ovary syndrome (PCOS). Arquivos Brasileiros de Endocrinologia e Metabologia. 2007;51(1):146-147.

Mariet W. Elting, Ted J.M. Korsen, Lyset T.M. Rekers-Mombarg, Joop Schoemaker. Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Human Reproduction, Volume 15, Issue 1, January 2000, Pages 24–28, https://doi.org/10.1093/humrep/15.1.24

Christopher L. Morgan, Sara Jenkins-Jones, Craig J. Currie, D. Aled ReesEvaluation of Adverse Outcome in Young Women with Polycystic Ovary Syndrome Versus Matched, Reference Controls: A Retrospective, Observational Study. The Journal of Clinical Endocrinology & Metabolism, Volume 97, Issue 9, 1 September 2012, Pages 3251–3260,

Mei-JouChenM.D., Ph.D.abHong-NerngHoM.D.Hepatic manifestations of women with polycystic ovary syndrome. Best Practice & Research Clinical Obstetrics & Gynaecology

Volume 37, November 2016, Pages 119-128

Festi D., Colecchia A., Sacco T., Bondi M., Roda E., Marchesini G. Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obesity Reviews. 2004;

Cotrim H. P. Doença hepática gordurosa não alcoólica. Sociedade Brasileira de Hepatologia; 2009.

Williams C. D., Stengel J., Asike M. I., et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140(1):124–131.

Compher C. W., Badellino K. O., Boullata J. I. Vitamin D and the bariatric surgical patient: a review. Obesity Surgery. 2008;18(2):220–224.

Lira A. R. F., Oliveira F. L. C., Escrivão M. A. M. S., Colugnati F. A. B., Taddei J. A. A. C. Hepatic steatosis in a school population of overweight and obese adolescents. Jornal de Pediatria. 2010;86(1):45–52.

Sociedade Brasileira de Cardiologia. I Diretriz brasileira de diagnóstico e tratamento da síndrome metabólica. Revista da Sociedade Brasileira de Hipertensão. 2004;7(4):p. 130.

Grundy S. M., Cleeman J. I., Daniels S. R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735–2752.




DOI: https://doi.org/10.34119/bjhrv5n3-239

Refbacks

  • There are currently no refbacks.